" class="no-js "lang="en-US"> seqWell Archives - Medtech Alert
Monday, October 07, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

seqWell Appoints Dr Amy Liao to Board of Directors

seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, […]

seqWell and Element Biosciences Partner to Demonstrate Sequencing Performance of Multiplexed plexWell Technology With the AVITI System

seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, today […]

seqWell’s plexWell Technology Selected by California Conservation Genomics Project for Conservation Genomics Research

seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ […]

Codexis and seqWell Announce Strategic Investment and Partnership Initiation

Codexis, Inc. (Nasdaq: CDXS) and seqWell, Inc. today announced the initiation of a strategic partnership […]

seqWell Appoints New Commercial Team, Led by Chief Commercial Officer Steve Smith

seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ multiplexing […]

TGen Looks Beyond COVID-19 as it Advances Pathogen Sequencing

Amidst the darkness of the pandemic, a shining light from the COVID-19 response is the […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more